Project Details
| Status | Active |
|---|---|
| Effective start/end date | 09/8/25 → 12/11/26 |
Funding
- IQVIA Incorporated: $163,342.60
Ono Pharmaceutical: A Phase II, 26-Week, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of ONO-2020 in Patients with Mild to Moderate Alzheimer's Disease
- Palekar, Nikhil (PI)
- Christodoulou, Christopher (CoPI)
Project: Research